spesolimab
boehringer ingelheim
['spesolimab', 'imab ']
congress #eadvcongress | maja mockenhaupt spoke about spesolimab safety in gpp, ppp and ad across 5 clinical trials. the safety profile of spesolimab across the trials was comparable to placebo, and frequency of aes was similar across trials.
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education.